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Background: Mitogen- and Stress-Activated Kinase 1 (MSK1) is a nuclear kinase that serves as active link between
extracellular signals and the primary response of gene expression. However, the involvement of MSK1 in malignant
transformation and cancer development is not well understood. In this study, we aimed to explore the role of
MSK1 in Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1)-promoted carcinogenesis of nasopharyngeal
carcinoma (NPC).
Methods: The level of MSK1 phosphorylation at Thr581 was detected by the immunohistochemical analysis in NPC
tissues and normal nasopharynx tissues, and its correlation with LMP1 was analyzed in NPC tissues and cell lines.
Using MSK1 inhibitor H89 or small interfering RNA (siRNA)-MSK1, the effects of MSK1 on LMP1-promoted CNE1
cell proliferation and transformation were evaluated by CCK-8 assay, flow cytometry and focus-forming assay
respectively. Furthermore, the regulatory role of MSK1-mediated histone H3 phosphorylation at Ser10 on the
promoter activity and expression of Fra-1 or c-Jun was determined by reporter gene assay and western blotting analysis.
Results: Immunohistochemical analysis revealed that the level of MSK1 phosphorylation at Thr581 was significantly
higher in the poorly differentiated NPC tissues than that in normal nasopharynx tissues (P < 0.001). Moreover, high level
of phosphorylated MSK1 was positively correlated with the expression of LMP1 in NPC tissues (r = 0.393, P = 0.002)
and cell lines. MSK1 inhibitor H89 or knockdown of MSK1 by siRNA dramatically suppressed LMP1-promoted CNE1
cell proliferation, which was associated with the induction of cell cycle arrest at G0/G1 phase. In addition, the
anchorage-independent growth promoted by LMP1 was blocked in MSK1 knockdown cells. When the activity or
expression of MSK1 was inhibited, LMP1-induced promoter activities of Fra-1 and c-Jun as well as their protein
levels were greatly reduced. It was found that only H3 WT, but not mutant H3 S10A, dramatically increased LMP1
induction of Fra-1 and c-Jun genes compared with mock cells.
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Conclusion: Increased MSK1 activity is critically important for LMP1-promoted cell proliferation and transformation in
NPC, which may be correlated with its induction of Fra-1 and c-Jun through phosphorylation of histone H3 at Ser10.
Keywords: MSK1, NPC, EBV-LMP1, Transformation, Fra-1, c-JunBackground
Nasopharyngeal carcinoma (NPC) is a particularly com-
mon tumor in areas of southern China and South-East
Asia, reaching a peak incidence of 20-30 cases per
100,1000 per year [1]. Its occurrence involves the inter-
action of host genetic alterations with environmental
factors, especially infection by Epstein-Barr virus (EBV)
[2, 3]. EBV-encode latent membrane protein 1 (LMP1) is
essential for the maintenance of latent infection and EBV-
mediated malignant transformation [3, 4]. The C-terminal
tail of LMP1 provides docking sites for the recruitment
and activation of signaling adapter proteins, which triggers
various downstream oncogenic signaling pathways, such
as NF-κB, MAPK, PI3K and JAK/STAT pathways [5].
However, it is largely unknown what key effector proteins
are induced and essentially promote cell transformation in
the LMP1-triggered signaling events.
Mitogen- and stress-activated kinase 1 (MSK1) is a nu-
clear serine/threonine protein kinase that is mainly acti-
vated by both ERKs and p38 MAPKs. Because of its dual
activation mode, MSK1 is able to integrate various
physiological and pathological stimuli including mito-
genic signals, cellular stress and pro-inflammatory cyto-
kines [6]. MSK1 has been recognized as a versatile
kinase regulating gene transcription at multiple levels.
MSK1 directly phosphorylates various transcription fac-
tors, including cAMP-responsive element binding pro-
tein (CREB), activating transcription factor 1 (ATF1),
signal transducers and activators of transcription 3
(Stat3), the p65 subunit of NF-κB, thereby alters their
ability of binding to target DNA or recruitment of re-
quired coactivator [7–9]. MSK1 also mediates the phos-
phorylation of chromatin protein histone H3 and high
mobility group 14 (HMG14), which induces chromatin
relaxation and contributes to gene activation, termed as
“nucleosomal response” [10]. MSK1-mediated histone H3
phosphorylation at Ser10 is critical for epidermal growth
factor (EGF), 12-O-tetradecanoylphorbol-13-acetate (TPA)
and oncogene (e.g. H-ras)-induced cell transformation,
which is associated with the induction of immediate-early
(IE) genes such as c-Fos, c-Jun and c-Myc [11–13]. Over-
active Ras-MAPK pathway and elevated MSK1 activity
were observed in various cancerous tissues and cell lines
[14, 15]. MSK1 is responsible for histone H3 phosphoryl-
ation of estrogen-responsive Trefoil Factor-1 (TFF-1) pro-
moter in breast cancer MCF-7 cells [16]. MSK1 also
regulates transcriptional activation of NF-κB-dependentpro-inflammatory genes in response to cigarette smoke
[17]. These studies suggested that MSK1 might play an im-
portant role in carcinogenesis through aberrant histone
modifications and transcriptional regulation. Our previous
study demonstrated that phosphorylation of histone H3 at
Ser10 mediated by MSK1 might be a crucial epigenetic
change in LMP1-promoted carcinogenesis of NPC [18].
However, it is not completely clear whether the activation
of MSK1 directly affects LMP1-promoted cell proliferation
and transformation in NPC.
In the present study, we found that MSK1 was abnor-
mally activated in both primary NPC tissues and NPC cell
lines, and closely related to the expression of LMP1. More-
over, MSK1 activity was required for LMP1-promoted cell
proliferation and transformation of NPC, which was asso-
ciated with the induction of Fra-1 and c-Jun by phosphor-
ylation of histone H3 at Ser10. These findings provide a
better understanding to the importance of MSK1-mediated
nucleosomal response in the LMP1-induced malignant
transformation and carcinogenesis.
Methods
Patients, tissue specimens and cell lines
Nasopharyngeal carcinoma tissue microarray (catalog
no. NPC961) was from US Biomax (Rockville, MD),
including 33 cases of poorly differentiated NPC tissues,
26 cases of adjacent normal tissues, and 10 cases of nor-
mal nasopharyngeal tissues. In addition, 20 cases of
poorly differentiated NPC tissues were obtained from
the First Affiliated Hospital of Guangdong Medical Col-
lege, Zhanjiang, China. The patients received no other
therapies, such as radiation or chemotherapy, prior to
operation. All samples were confirmed by pathological
examination and staging was performed according to the
1997 NPC staging system of the UICC. In the 53 NPC
cases, there were 40 male and 13 female with age ran-
ging from 26 to 62 years (median, 43.9 years). Informed
consent was obtained from all patients, and this study
was approved by the Institutional Ethics Committee of
Guangdong Medical College.
CNE1 cells, an EBV-negative and well-differentiated
human NPC cell line, were cultured in RPMI 1640
medium supplemented with 10 % fetal bovine serum
(GIBCO, Carlsbad, CA, USA). CNE1G (CNE1 stably
transfected with PAT-GFP) and CNE1GL (CNE1 stably
transfected with PAT-GFP-LMP1) cells were provided by
Dr. Xiaoyi Chen, Guangdong Medical College [19], and
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scribed above, containing 0.5 μg/ml puromycin (Sigma-
Aldrich, St. Louis, MO, USA).
Plasmids, transfection and establishing stable cell lines
To construct the siRNA-mock (si-mock) or siRNA-MSK1
(si-MSK1), the mU6pro vector (a gift from Dr. Zigang
Dong, Hormel Institute, University of Minnesota, Austin,
Minnesota, USA) was digested with XbaI and BbsI. The
annealed synthetic primers (si-mock: 5′-TTTGACTAC
CGTTGTTATAGGTGTTCAAGAGACACCTATAACAA
CGGTAGTTTTTT-3′ and antisense 5′- CTAGAAAAAA
ACTACCGTTGTTATAGGTGTCTCTTGAACACCTAT
AACAACGGTAGT; si-MSK1: sense 5′-TTTGAGACCT
AATTCAGCGTCTTTTCAAG AGAAAGACGCTGAAT
TAGGTCTTTTTT-3′ and antisense 5′-CTAGAAAAAA
GACCT AATTCAGCGTCTTTCTCTTGAAAAGACGC
TGAATTAGGTCT-3′) were then introduced following
the recommending protocols. The recombinant plasmids
were confirmed by agarose gel electrophoresis and DNA
sequencing. The plasmids were transfected into CNE1
cells using JetPEI (Polyplus, llkirch) according to the man-
ufacturer’s protocol. Stable CNE1 cells expressing si-mock
or si-MSK1 were established with pcDNA6.0/myc-HisB as
selection marker. Transfected cells were selected in
medium containing 2 μg/ml blasticidin (Sigma-Aldrich,
St. Louis, MO), and the expression level of MSK1 was
confirmed by Western blotting analysis.
The pcDNA3.0 and pcDNA3.0-LMP1 vectors were
kindly provide by Dr Ellen Cahir- McFarland, Brigham
and Women’s Hospital, Boston, Massachusetts, USA.
AP-1 reporter vector pRTU14 was kindly provided by
Dr ArndKieser, Helmholtz ZentrumMünchen, Munich,
Germany [20]. To construct the Fra-1 and c-Jun promoter
luciferase reporter vectors, DNA fragments of 5′-flanking
region of the human Fra-1 gene (-379 to -238) [21] and
c-Jun gene (-117 to -50) [22] were synthesized and
inserted into a basal promoter luciferase reporter vector
(pGL3) respectively. The pcDNA6.0/myc-His B-histone
H3 wide-type (pcDNA6.0-H3 WT) and pcDNA6.0/myc-
His B-histone H3 S10A mutant (pcDNA6.0-H3 S10A)
were constructed as reported previously [18]. pcDNA6.0-
H3 WT or pcDNA6.0-H3 S10A stably transfected CNE1
cells were selected in medium containing 2 μg/ml blastici-
din. Expression of vectors was confirmed with an antibody
against the His epitope by Western blotting analysis.
Immunohistochemical staining
Fixed tissue samples were sectioned (4 μm), deparaffinized,
rehydrated, and subjected to heat-induced antigen retrieval
in sodium citrate buffer (0.01 M, pH 6.0). Endogenous per-
oxidase activity and non-specific antigen were blocked with
3 % hydrogen peroxide and normal goat serum. The sec-
tions were incubated with the primary antibodies againstphosphorylated MSK1 (Thr581) or LMP1 overnight at
4 °C. HRP-conjugated secondary antibodies (ChemMate
Envision Detection Kit, DAKO) were applied onto the sec-
tions and incubated for 30 min at room temperature. 10 %
normal goat serum was used to replace primary antibodies
as a negative control.
The slides were reviewed and scored independently by
two pathologists. Phosphorylated MSK1 at Thr581 was
expressed in the cell nucleus and the staining was scored
according to its intensity (0, no staining; 1, weakly stain-
ing; 2, moderately staining; 3, strongly staining) and
the percentage of positive cells (0, <5 % positive cells;
1, 5 %-25 % positive cells; 2, 26-50 % positive cells;
3, >50 % positive cells). The final expression score was
calculated from “intensity score” multiplied by “percent-
age”. For statistical analysis, cases with weighted scores
of more than 3 were defined as high expression, other-
wise they were defined as low expression. Staining of
LMP1 appeared on the cell membrane or/and in the
cytoplasm. The expression of LMP1 was scored as positive
(≥10 %) and negative (<10 %) based on the percentage of
stained cells [23]. In order to detect the expressions of
LMP1 and phosphorylated MSK1 at Thr581 in CNE1G and
CNE1GL cells, they were immunocytochemically stained
using the same method as for the clinical specimens.
Cell proliferation assay
CNE1G and CNE1GL cells were seeded in 96-well plates
(2 × 103 cells per well) and incubated with different con-
centrations of H89 (Cell Signaling Technology, Beverly,
MA). The si-mock or si-MSK1 stable CNE1 cells were
transfected with pcDNA3.0 or pcDNA3.0-LMP1 plasmid
and then seeded in 96-well plates with 100 μl cell suspen-
sion in each well (1 × 103 cells per well). After culturing for
various periods of time, 10 μl of CCK-8 solution (Dojindo
Laboratories, Kumamoto, Japan) was added to each well,
and cells were then incubated for 4 hour at 37 °C. Absorb-
ance was measured at 450 nm using Synergy2 Multi-Mode
Microplate Reader (BioTek, Winooski, VT, USA). The
assay was conducted in five replicate wells for each sample
and three parallel experiments were performed.
Cell cycle analysis
CNE1 cells were seeded in 6-well plates and then transi-
ently transfected with pcDNA3.0 or pcDNA3.0-LMP1
plasmid. H89 was added to the culture medium with dif-
ferent concentrations every 12 h after transfection. The
si-mock or si-MSK1 stable CNE1 cells were transfected
with pcDNA3.0 or pcDNA3.0-LMP1 plasmid and cul-
tured for 48 h. The cells were harvested with trypsin,
fixed with 70 % ice-cold ethanol, and stained with propi-
dium iodide (PI). Then cell cycle distributions were ana-
lyzed by flow cytometry and the percentage of cells in
G1/G0, S, or G2/M phase was calculated using ModFit
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triplicate experiments.
Colony forming assay
CNE1G and CNE1GL cells were seeded in 6-well plates
(400 cells per well) and incubated with different concen-
trations of H89. After culturing for 2 weeks, colonies were
fixed with methanol and stained with 0.5 % crystal violet.
The number of colonies containing 50 cells or more was
counted under an inverted microscope and the mean
value from three replicate wells was calculated. Data are
representative of at least three independent experiments.
Anchorage-independent cell transformation assay
LMP1-induced cell transformation was investigated in
si-mock or si-MSK1 stable CNE1 cells. In brief, the cells
were transfected with pcDNA3.0 or pcDNA3.0-LMP1
plasmid and then seeded in 1 ml of 0.3 % basal medium
Eagle’s agar containing 10 % FBS (800 cells per well).
After culturing for 3 weeks, the number of colonies con-
taining 50 cells or more was counted under an inverted
microscope and the mean value from three replicate
wells was calculated. Data are representative of at least
three independent experiments.
Reporter gene assay
Fra-1 or c-Jun promoter activity and AP-1 activity were
determined by the luciferase reporter gene assay. Cells
were transiently cotransfected with various firefly lucifer-
ase reporter gene and pRL-TK vector (Promega, China).
The pRL-TK vector expressing Renilla luciferase was
cotransfected for normalizing the transfection efficiency.
At 36 hours after transfection, cells were lysed with pas-
sive lysis buffer (Promega) for 20 min with gently shaking.
The firefly luciferase and Renilla luciferase activities were
measured with cell lysates using the Dual-Luciferase assay
system (Promega) in FB12 Luminometer (Berthold detec-
tion system). The results were expressed as firefly lucifer-
ase activity normalized against Renilla luciferase activity.
Data were derived from the mean value of triplicate sam-
ples and recorded as relative luciferase activity (fold or %).
All experiments were done at least in triplicate.
Protein extraction and western blot analysis
Cells were washed twice with cold PBS, and total protein
was extracted with RIPA lysis buffer (Beyotime Ins. Bio,
China) with protease inhibitor PMSF (Sangon, China).
The isolation of histone was performed as described previ-
ously [18]. Protein concentration was determined by
the bicinchoninic acid (BCA) assay (Pierce, Rockford, IL,
USA). Samples containing equal amount of protein were
resolved by SDS-PAGE and transferred to PVDF mem-
branes. The membranes were probed with primary anti-
bodies against phosphorylated or total MSK1(1:500), c-Jun(1:500), His-tag (1:500), histone H2A (1:1000) (all from
Cell Signaling Technology, Beverly, MA), Fra-1(1:500,
Santa Cruz Biotechnology, CA) and EBV LMP1 (CS1-4)
(1:1000, DAKO, Glostrup), then incubated with infrared-
dye-conjugated secondary antibodies (1:10000, Rockland
Immunochemicals, Gilbertsville, PA) for 1 h at room
temperature. Protein bands were visualized by Odyssey In-
frared Imaging System (LI-COR Biotechnology, Lincoln,
NE, USA) and quantified using the Quantity One software
(Bio-Rad, USA).
Statistical analysis
The SPSS version 16.0 software package and GraphPad
Prism were used for the statistical analysis and data plot-
ting. The Chi-square test was applied to examine the dif-
ference of phosphorylated MSK1 between NPC tissues
and normal nasopharynx tissues as well as the relationship
between phosphorylated MSK1 and LMP1 expression.
Quantitative values were expressed as means ± SD. Stu-
dent t-test was used to compare the mean value of each
group. P < 0.05 was considered statistically significant.
Results
The level of MSK1 phosphorylation at Thr581 and its
correlation with LMP1 in NPC tissues
In order to assess the activation of MSK1 in the tumori-
genesis of NPC, we analyzed the level of MSK1 phosphor-
ylation at Thr581 in 53 archived paraffin-embedded NPC
specimens and 36 adjacent/normal nasopharynx speci-
mens using immunohistochemical staining. Phosphory-
lated MSK1 was expressed in cell nucleus (Fig. 1a, b). As
shown in Table 1, the level of MSK1 phosphorylation at
Thr581 was significantly higher in the poorly differenti-
ated NPC tissues than that in normal nasopharynx tissues
(χ2 = 15.137, P < 0.001). This revealed that the elevated
phosphorylation of MSK1 at Thr581 might be involved in
the malignant transformation of NPC cells.
We further determined the relationship between phos-
phorylated MSK1 at Thr581 and LMP1 expression in 53
cases of NPC specimens. The LMP1 expression was lo-
cated on cell membrane and cytoplasm (Fig. 1c, d). In
NPC, 30 out of 53 (56.6 %) cases showed LMP1 expres-
sion. As shown in Table 2, there was a positive correlation
between LMP1 expression and increased phosphorylation
of MSK1 at Thr581 in NPC tissues (r = 0.393, P =0.002).
LMP1 induces MSK1 activation via ERK-MAPK pathway in
CNE1 cells
To investigate whether LMP1 directly induced activation
of MSK1 in NPC cells, we examined the relative level of
phosphorylated MSK1 at Thr581 between CNE1G and
CNE1GL cells by immunocytochemical staining. CNE1GL
cells stably expressed LMP1 showed substantially high
level of MSK1 phosphorylation compared with control
Fig. 1 Expressions of phosphorylated MSK1 (Thr581) and LMP1 in nasopharyngeal carcinoma (NPC) and normal nasopharynx tissues by
immunohistochemistry. (a) High expression of phosphorylated MSK1 (Thr581) in poorly differentiated NPC tissues. (b) Low expression of
phosphorylated MSK1 (Thr581) in normal nasopharynx tissues. (c) Positive expression of LMP1 in poorly differentiated NPC tissues. (d) Negative
expression of LMP1 in poorly differentiated NPC tissues. Images were captured at × 200 magnification (left) and × 400 magnification (right)
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which was consistent with previous findings on MSK1 kin-
ase activity [18]. In addition, CNE1 cells were transiently
transfected with pcDNA3.0-LMP1, and the expression of
phosphorylated MSK1 at Thr581 was examined by western
blotting analysis. As shown in Fig. 2b, EBV-LMP1 could in-
duce a dramatic increase of MSK1 phosphorylation at
Thr581 in CNE1 cells. To further explore the signal mech-
anism mediated the activation of MSK1, PD98059, a
specific ERK1/2 inhibitor, was used to treat the LMP1-
transfected CNE1 cells. Our results showed that PD98059
obviously suppressed LMP1-induced phosphorylation of
MSK1 at Thr581 in a dose-dependent manner (Fig. 2c).
H89 inhibits LMP1-promoted CNE1 cell proliferation by
delaying G1/S transition
To determine whether MSK1 activity is crucial for LMP1-
promoted cell proliferation in NPC cells, H89, a potent in-
hibitor of MSK1, was used to treat the LMP1-transfected
CNE1 cells. As expected, H89 markedly inhibited the
LMP1-induced phosphorylation of MSK1 at Thr581 in a
dose-dependent manner, but the total MSK1 protein level
did not change (Fig. 3a). We assessed the effect of H89 onTable 1 The level of phosphorylated MSK1 (Thr581) in
nasopharyngeal carcinoma (NPC) and normal nasopharynx tissues
Sample n p-MSK1 P-value
High Low
poorly differentiated NPC 53 29 24 <0.001
normal nasopharynx 36 5 21LMP1-promoted cell proliferation with different concen-
trations of H89 over varying periods. The results showed
that H89 effectively suppressed LMP1-promoted cell pro-
liferation in a time- and dose-dependent manner (Fig. 3b).
In addition, H89 was found to dramatically block the col-
ony formation promoted by LMP1 (Fig. 3c). The effect of
H89 on cell cycle distributions was analyzed by flow cy-
tometry. As shown in Fig. 3d, CNE1 cells expressing
LMP1 showed a decrease of cells in G0/G1 phase, and an
increase of cells in the S and G2/M phases compared with
mock cells, which indicated that LMP1 can accelerate cell
cycle progression to promote the proliferation of CNE1
cells. However, the treatment of H89 caused a great accu-
mulation of cells in the G0/G1 phase and a decrease in the
S phase in a dose-dependent manner. These results sug-
gested that H89 suppressed LMP1-promoted cell prolifer-
ation because of an impaired G1/S cell cycle transition.
Knockdown of MSK1 suppresses LMP1-promoted CNE1
cell proliferation and anchorage-independent growth
To ensure that the inhibition of cell proliferation was not
a consequence of some other effect of H89, we designedTable 2 Correlation between LMP1 expression and
phosphorylated MSK1 (Thr581) in nasopharyngeal carcinoma
(NPC) tissues
Groups LMP1 r P-value
+ -
p-MSK1 high 22 7 0.393 0.002
low 8 16
Fig. 2 LMP1 induces phosphorylation of MSK1 at Thr581 in CNE1 cells. (a) CNE1G and CNE1GL cells were starved for 36 h by incubating in
serum-deprived 1640 and subjected to immunocytochemical staining. No expression and positive staining of LMP1 (a, b) and different expression
of phosphorylated MSK1 at Thr581 (c, d) in CNE1G and CNE1GL cells (magnification, ×200). (b) CNE1 cells were transfected with pcDNA3.0 or
pcDNA3.0-LMP1. After 24 h of transfection, cells were starved for another 24 h by incubating in serum-deprived 1640 and then harvested. The
expressions of LMP1 and phosphorylated MSK1 at Thr581 were detected by Western blotting. (c) CNE1 cells were transfected with pcDNA3.0 or
pcDNA3.0-LMP1 vector. PD98059 was added to the culture medium at the concentration indicated every 12 h after transfection. The expression
of phosphorylated MSK1 was detected by Western blotting. β-actin was used as loading control. Corresponding signaling intensities of
phosphorylated MSK1 were densitometrically determined and normalized to total MSK1 in each lane and is given below in each data
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siRNA (si-mock) for transfection into CNE1 cells. Immu-
noblot analysis revealed that CNE1 cells stably transfected
with si-MSK1 showed a suppression of endogenous MSK1
expression of up to 80 % compared with si-mock control
cells (Fig. 4a). The si-mock or si-MSK1 stable CNE1 cells
were transfected with pcDNA3.0 or pcDNA3.0-LMP1,
and then cell proliferation and cell cycle profile were
analyzed. Consistent to the effect of treatment with
H89, the knockdown of MSK1 (si-MSK1/LMP1) markedly
suppressed LMP1-promoted cell proliferation, and caused
cell cycle arrest at the G0/G1 phase compared with the si-
mock control cells (si-mock/LMP1) (Fig. 4b and 4c). Fur-
thermore, the effect of MSK1 knockdown on anchorage-
independent cell transformation was evaluated by soft
agar assay. As shown in Fig. 4d, the knockdown of MSK1
strongly blocked the formation of transformed colonies
induced by LMP1 compared with si-mock control cells.
The inhibition was obvious not only in colony number,but also in colony size. These data indicated that MSK1
activity was required for LMP1-promoted malignant
phenotype of CNE1 cells.
MSK1 regulates LMP1-induced expressions of Fra-1 and c-
Jun in CNE1 cells
MSK1 has been showed to play an important role in
transcriptional and epigenetic regulation of genes in re-
sponse to extracellular stimuli. We further explored
whether the heightened activity of MSK1 is responsible
for LMP1-induced gene activation involved in cell prolif-
eration and transformation. LMP1 was found to upregu-
late activator protein (AP-1) transcriptional activity [24],
but its mechanisms involved are still not completely
clear. Examining the expressions of AP-1 proteins, we
found that LMP1 can increase the expressions of en-
dogenous Fra-1 and c-Jun proteins. However, the treat-
ment of H89 dramatically suppressed the promoter
activity of Fra-1 or c-Jun induced by LMP1 in a dose-
Fig. 3 H89 inhibited LMP1-promoted CNE1 cell proliferation. (a) CNE1 cells were transfected with pcDNA3.0 or pcDNA3.0-LMP1. H89 was added
to the culture medium at the concentration indicated every 12 h after transfection. The expression of phosphorylated MSK1 at Thr581 was
detected by Western blotting. β-actin was used as loading control. (b) CNE1G and CNE1GL cells were seeded in 96-well plates and incubated with
different concentrations of H89 for 24 h or 48 h. Cell proliferation was estimated using CCK-8 assay. Data are presented as mean ± SD for three
independent experiments. *P < 0.05; **P < 0.001, compared with CNE1GL cells untreated with H89. (c) CNE1GL cells were incubated with different
concentrations of H89 for 2 weeks, and then the ability of colony formation was evaluated. *P < 0.01; **P < 0.005, compared with CNE1GL cells
untreated with H89. (d) The effect of H89 on LMP1-induced cell cycle distributions was analyzed by flow cytometric assay. Data are expressed as
the percentage of cells in G0/G1, S, or G2/M phase. *P < 0.05; **P < 0.005, compared with LMP1-transfected CNE1 cells untreated with H89
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protein levels (Fig. 5b). Next, we examined the effect of
MSK1 knockdown on the induction of Fra-1 or c-Jun
gene. As shown in Fig. 5c and 5d, LMP1-promoted in-
duction of Fra-1 and c-Jun was effectively abrogated in
si-MSK1 stably transfected cells compared with si-mock
control cells. Furthermore, AP-1 activation induced by
LMP1 was significantly blocked when MSK1 activity or
expression was reduced in CNE1 cells, consistent to that
observed for Fra-1 or c-Jun activity. Taken together,
these results showed that the increased MSK1 activity in
LMP1-transformed CNE1 cells is critically important for
induction of Fra-1, c-Jun promoter and AP-1 activation.Phosphorylation of histone H3 at Ser10 is involved in
LMP1 induction of Fra-1 and c-Jun in CNE1 cells
It was proposed that increased phosphorylation of histone
H3 at Ser10 by activation of Ras-MAPK pathway and
MSK1 may contribute to the aberrant gene expression ob-
served in oncogene-transformed cells [25]. Our previous
studies showed that MSK1 mediated LMP1-induced phos-
phorylation of histone H3 at Ser10 in CNE1 cells [18].
Thus, we further determined whether phosphorylation of
histone H3 at Ser10 is involved in LMP1-promoted activa-
tion of Fra-1 or c-Jun. The pcDNA6.0-H3 WT or mutant
pcDNA6.0-H3 S10A plasmid was introduced into CNE1
cells (Fig. 6a), then the LMP1-promoted Fra-1 or c-Jun
Fig. 4 Knockdown of MSK1 suppressed LMP1-promoted CNE1 cell proliferation and anchorage-independent growth. (a) The expression of MSK1
was analyzed in the CNE1 cells stably transfected with si-mock or si-MSK1 by Western blotting. si-MSK1 efficiently suppressed the endogenous
MSK1 protein level in CNE1 cells. (b) CNE1 cells stably expressing si-mock or si-MSK1 were transfected with pcDNA3.0 or pcDNA3.0-LMP1, and
cell proliferation was estimated using CCK-8 assay. Data are presented as mean ± SD for three independent experiments. *P < 0.05; **P < 0.005,
compared with si-mock/LMP1 cells. (c) The effect of MSK1 knockdown on LMP1-induced cell cycle distributions was analyzed by flow cytometric
assay. Data are expressed as the percentage of cells in G0/G1, S, or G2/M phase. *P < 0.05; **P < 0.005, compared with si-mock/LMP1 cells. (d) CNE1 cells
stably expressing si-mock or si-MSK1 were transfected with pcDNA3.0 or pcDNA3.0-LMP1, and soft agar assay was performed to detect the
anchorage-independent growth capability. *P < 0.005, compared with si-mock/LMP1 cells
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LMP1-promoted transcriptional activity of Fra-1 or c-Jun
was significantly increased in CNE1 cells overexpressing
H3 WT compared with mock control cells. In contrast,
the histone H3 S10A mutant partly suppressed LMP1-
promoted induction of Fra-1 and c-Jun genes compared
with H3 WT cells. We next detected the effect of histone
H3 on the expression of Fra-1 or c-Jun proteins. Results
showed that only H3 WT, but not H3 S10A, cells dramat-
ically increased endogenous Fra-1 and c-Jun protein levels
promoted by LMP1 compared with mock control cells
(Fig. 6c). Taken together, these data suggested that histone
H3 phosphorylation at Ser10 by MSK1 seems to be in-
volved in LMP1-induced Fra-1 and c-Jun gene activation
in CNE1 cells.
Discussion
MSK1 regulates transcription and cellular function at
multiple levels and thereby exerts extensive effects in celltransformation, inflammation, neuronal plasticity, cardiac
hypertrophy and other biological events [6]. MSK1 has
been showed to be activated by either the ERK1/2 or p38
pathways depending on the specific stimuli. MSK1 activa-
tion is regulated by multiple phosphorylation sites. The
phosphorylation at Thr581 located within the C-terminal
kinase domain is essential for activation of MSK1. The
mutation of Thr581 to an alanine residue prevented the
activation of MSK1 in response to extracellular stimuli
[26]. The elevated phosphoylation of MSK1 at Thr581 was
observed in vulnerable neurons in Alzheimer's disease
(AD) and the epidermis in lesional psoriatic skin, repre-
sented the activated ERK/p38 MAPK pathway and in-
creased MSK1 activity [27, 28]. Various tumor promoters,
such as EGF, TPA, or UVC and oncogenes have been
showed to induce activation of MSK1 [29–31]. Further-
more, ~30 % of human cancers (e.g. colon, pancreatic,
lung and breast cancers) have an overactive Ras-MAPK
pathway and presumably elevated MSK1 activity even in
Fig. 5 MSK1 regulates LMP1-induced transcriptional activation of Fra-1 and c-Jun in CNE1 cells. (a) CNE1 cells were transfected with pcDNA3.0
or pcDNA3.0-LMP1. H89 was added to the culture medium at the concentration indicated every 12 h after transfection. The firefly luciferase
activity was measured and normalized against Renilla luciferase activity respectively. Each bar represents the mean ± SD of three independent
experiments. *P < 0.05; **P < 0.005, compared with LMP1-transfected CNE1 cells untreated with H89. (b) The effect of H89 on Fra-1 or c-Jun
protein levels induced by LMP1 was examined by Western blotting. (c) CNE1 cells stably expressing si-mock or si-MSK1 were transfected with
pcDNA3.0 or pcDNA3.0-LMP1. At 36 hours after transfection, the firefly luciferase activity was measured and normalized against Renilla luciferase
activity respectively. *P < 0.01; **P < 0.005, compared with si-mock/LMP1 cells. (d) The effect of MSK1 knockdown on Fra-1 or c-Jun protein levels
induced by LMP1 was examined by Western blotting. β-actin was used as loading control
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study, we found that the level of phosphorylated MSK1 at
Thr581 was significantly high in poorly differentiated
NPC tissues. It is indicated that the increased MSK1 activ-
ity might be an important event in the pathogenesis and
progression of NPC.
LMP1, an important oncoprotein encoded by EBV,
was found to be able to transform cell lines and induced
multiple morphological and phenotypic alterations [4].
When expressed in epithelial cells, LMP1 exerted
growth-promoting effects and modulated squamous epi-
thelial differentiation [32, 33]. Functionally, LMP1 mimics
a constitutively activated tumor necrosis factor receptor
(TNFR), CD40, engaging a variety of signaling in a ligand-
independent manner [34]. Activation of NF-κB, AP-1 and
JAK3/STAT mediates various downstream pathological ef-
fects of LMP1 expression [5]. It has been demonstrated
that LMP1 activates ERK-MAPK in epithelial cells via
the canonical Raf-MEK-ERK-MAPK pathway in a Ras-
independent manner [35]. In this study, we found that the
elevated level of MSK1 phosphorylation at Thr581 in
NPC tissues was closely related to LMP1 expression.
Moreover, LMP1 induced phosphorylation of MSK1 atThr581 under the serum-starved condition in CNE1 cells.
But ERK1/2 inhibitor PD98059 obviously suppressed
LMP1-induced phosphorylation of MSK1. The findings
suggested that EBV-LMP1 could constitutively activate
MSK1 via ERK1/2-MAPK signaling pathway in NPC.
It has been reported that MSK1 played a positive role in
the control of cell proliferation of HaCaT keratinocytes
[36] and EGF- or TPA-induced neoplastic cell transform-
ation of JB6 Cl41 cells [29]. The inhibition of MSK1 acti-
vation significantly suppressed malignant phenotype of
Hras-transformed cells [13]. Furthermore, MSK1/2 knock-
out mice developed significantly fewer skin tumors
compared with wild-type mice in DMBA-initiated and
TPA-promoted multistage skin carcinogenesis [37]. In
the present study, we found that MSK1 directly regu-
lated LMP1-promoted cell proliferation and transform-
ation in CNE1 cells. When expressed in CNE1 cells,
LMP1 can exert growth-promoting effects through accel-
erating cell cycle progression. However, the inhibition of
MSK1 activity or expression dramatically suppressed
LMP1-promoted cell proliferation by causing cell cycle
arrest at G1-S phase transition. The malignant potential
of LMP1-transformed CNE1 cells, represented by the
Fig. 6 Phosphorylation of histone H3 at Ser10 is involved in LMP1 induction of Fra-1 and c-Jun in CNE1 cells. (a) The expressions of H3 WT and
H3 S10A mutant in stably transfected CNE1 cells were detected with an anti-His antibody against His-histone H3 by Western blotting. Histone
H2A was used as loading control. (b) CNE1 cells stably expressing mock, H3 WT or mutant H3 S10A were transfected with pcDNA3.0 or pcDNA3.0-LMP1.
At 36 hours after transfection, the firefly luciferase activity was measured and normalized against Renilla luciferase activity respectively. *P< 0.01; **P< 0.005,
compared with mock/LMP1 cells. (c) The effect of overexpressing histone H3 WT or H3 S10A mutant on Fra-1 or c-Jun protein levels induced by LMP1
was examined by Western blotting. β-actin was used as loading control. Corresponding signaling intensities of Fra-1 or c-Jun were densitometrically
determined and normalized to β-actin in each lane and is given below in each data
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duced by the knockdown of MSK1. These results indi-
cated that MSK1 was involved in cell cycle regulation and
its activity was required for LMP1-promoted cell prolifer-
ation and transformation in CNE1 cells.
The role of MSK1 in cancer progression is varied because
of their many substrates and encompasses involvement in
cell proliferation, transformation and inflammation [6, 38].
Increased MSK1 activity in ras-transformed mouse fibro-
blasts was required for maintaining the steady-state levels
of Cox-2, Fra-1 and Jun and sustaining their ability to drive
the cancer process [13]. MSK1 was involved in regulating
the transcription of nuclear orphan receptor gene Nur77,
Nurr1 and Nor1 [39], the up-regulation of which has been
implicated in cell transformation [40]. The knockout of
both MSK1 and MSK2 resulted in a 50 % reduction in c-
Fos and JunB gene transcription in response to anisomycin
or UVC radiation, but the transcription of Egr-1 induced by
anisomycin was not affected [7]. It has been reported that
MSK1 activity was necessary for EGF- but not for TNFα-induced H3 Ser10 phosphorylation of the c-Fos promoter
[41]. These studies strongly suggested that MSK1 might
contribute to tumor promoter-induced cell transformation
and tumorigenic progression through regulating the aber-
rant expression of specific genes. However, it remains to be
resolved how MSK1 integrates the large variety of signals
and accounts for the observed stimulus-, target gene- and
cell-type-dependent specificity.
AP-1 is dimeric transcription factor mainly comprising
members of Jun family (c-Jun、JunB, and JunD) and Fos
family (c-Fos、FosB、Fra-1, and Fra-2). AP-1 dimers of
different composition exert significant difference in DNA
binding affinity and determine the target genes that it reg-
ulates [42]. AP-1 proteins are primarily considered to
be oncogenic and have been reported to involve in cell
transformation, proliferation, differentiation and apoptosis
[42, 43]. The regulation of AP-1 proteins occurs at the
level of transcription and/or post-transcriptional modifica-
tions. Fra-1, Fos-related antigen 1 encoding by Fosl1, di-
merizes with Jun family proteins and thereby regulates
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expressed in many kinds of epithelial tumors, and associ-
ated with poor prognosis of some squamous cell carcin-
omas [45, 46]. Fra-1 expression was also up-regulated in
NPC cells compared with non-malignant nasopharyngeal
epithelial cells [47]. Fra-1 was induced by EBV-LMP2A
dependent on the activated ERK1/2 pathway and was
essential for formation of AP-1 heterodimers mediating
LMP2A-triggered MMP9 expression [48]. A potential link
between LMP1 and Fra-1 comes from a previous study
showing constitutive induction of Fra-1 in LMP1-transgenic
mice [49]. c-Jun is a positive regulator of cell proliferation.
The deficiency of c-Jun in fibroblasts leads to a marked
proliferation defect due to the delay of cell cycle progres-
sion [50]. c-Jun played a pivotal role in Ras-induced cellular
transformation and malignancy [51]. TNF-α-stimulated
c-Jun expression preceded and was essential for subsequent
Fra-1 induction in pulmonary epithelial cells [52]. Previous
studies have been shown that LMP1 promoted the forma-
tion of c-Jun/JunB heterodimers leading to induction of
AP-1 activation through JNK-mediated phosphorylation of
c-Jun [53]. In this study, we found that LMP1 caused a sig-
nificant increase in the transcriptional activity of Fra-1 and
c-Jun dependent on MSK1 activity. Chemical and genetic
interference with MSK1 suppressed induction of Fra-1 and
c-Jun by LMP1, resulting in decreased AP-1 activity. These
findings indicated that MSK1 activity was critical in main-
taining LMP1-promoted expressions of Fra-1 and c-Jun,
which might alter AP-1 activation and its responsive genes.
Phosphorylation of histone H3 at Ser10 occurs in two
difference phases of cell cycle with opposite functions.
During mitosis, histone H3 Ser10 is globally phosphory-
lated by Aurora kinase, which facilitates compaction and
transcriptional repression [54]. During interphase, extra-
cellular stimuli also lead to phosphorylation of histone
H3 in a minute fraction of histone H3, in correlation
with rapid transcription induction of a subset of genes
[55]. Accumulating evidences have demonstrated that
phosphorylation of histone H3 at Ser10 in interphase is
involved in different signaling pathways and effector ki-
nases depending on specific stimulation and stress.
Akt1, ERK2 and Ribosomal subunit protein S6 kinase 2
(RSK2), but not MSK1, were responsible for arsenite-
induced phosphorylation of H3 at Ser10 [56], which was
associated with induction of Fos, Egr1 and IL-8 [57]. It
has been showed that PIM1 phosphorylated histone H3
at Ser10 on the nucleosome at the Myc-binding sites,
contributing to transcriptional activation of Fra-1 gene
[58]. Our previous study has revealed that LMP1 can
constitutively activate phosphorylation of histone H3 at
Ser10 in interphase through the activation of Ras-MAPK
pathway and MSK1 kinase in CNE1 cells [18]. In this
study, we found that overexpression of histone H3 WT
in CNE1 cells dramatically augmented LMP1 inductionof Fra-1 and c-Jun promoter activity compared with
mock control cells, but the increase of activity was partly
inhibited in the mutant H3 S10A cells. Constitutive acti-
vation of ERK-MSK1 pathway induced by LMP1 en-
hanced the level of phosphorylated histone H3 at Ser10
in H3 WT-overexpressing CNE1 cells. The elevated his-
tone H3 phosphorylation may contribute to the decon-
densed chromatin struction and releasing blocks in
elongation, which promotes the binding of transcription
factors to the promoter region leading to the aberrant
transcriptional activation of genes [55, 59]. The regula-
tion of Fra-1 or c-Jun gene is orchestrated by numerous
transcription factors, which themselves must be acti-
vated. Moreover, other post-translational modifications
of histone H3 such as methylation and acetylation might
also be involved. Nonetheless, it has been suggested that
phosphorylation of histone H3 at Ser10 mediated by
MSK1 was closely linked with LMP1-induced transcrip-
tional activation of Fra-1 and c-Jun genes.
Conclusions
In summary, these studies demonstrated a pivotal role of
MSK1-mediated nucleosomal response in LMP1-promoted
cell proliferation and transformation in NPC, which might
be associated with its induction of aberrant gene expres-
sion. Considering that MSK1 is the active link between
signaling cascades and the primary response of gene ex-
pression. It has been showed that MSK1/2 knock-out mice
are viable and fertile and have no obvious health defects
[7]. Therefore, MSK1 may consider as an ideal molecular
target for cancer chemotherapy and gene therapy in NPC.
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